0001209191-22-018065.txt : 20220310
0001209191-22-018065.hdr.sgml : 20220310
20220310200729
ACCESSION NUMBER: 0001209191-22-018065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220308
FILED AS OF DATE: 20220310
DATE AS OF CHANGE: 20220310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOBIN JAMES R
CENTRAL INDEX KEY: 0001190128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 22730816
MAIL ADDRESS:
STREET 1: C/O CURIS INC
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-08
0
0001237831
GLOBUS MEDICAL INC
GMED
0001190128
TOBIN JAMES R
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
1
0
0
0
Class A Common Stock
2022-03-08
4
M
0
4484
43.58
A
4484
D
Class A Common Stock
2022-03-08
4
S
0
4484
72.00
D
0
D
Class A Common Stock
2022-03-10
4
M
0
10000
43.58
A
10000
D
Class A Common Stock
2022-03-10
4
S
0
10000
70.0398
D
0
D
Stock Option (Right to Buy Class A Common Stock)
43.58
2022-03-08
4
M
0
4484
0.00
D
2029-01-22
Class A Common Stock
4484
20516
D
Stock Option (Right to Buy Class A Common Stock)
43.58
2022-03-10
4
M
0
10000
0.00
D
2029-01-22
Class A Common Stock
10000
10516
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.135, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
These options were granted on January 22, 2019 and are fully vested.
/s/ Kelly G. Huller, Attorney-in-Fact
2022-03-10